Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PREGABALIN 75 MG CAPSULE

Pregabalin
$0.0513per EA
DEA Schedule CV

Strength

75 mg/1

Manufacturer

Sun Pharmaceutical Industries Inc.

NDC

47335068888

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA091157

On Market Since

12/4/2019

Price History

1W

0.0%

1M

0.0%

3M

-2.5%

6M

-18.4%

1Y

-20.3%

3Y

-33.4%

5Y

-48.6%

All

-62.9%

Generic Alternatives

Save up to 1%

10 alternatives • Same active ingredient

PREGABALIN 75 MG CAPSULE
Generic
69367032609•Westminster Pharmaceuticals LLC
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
60687049501•American Health Packaging
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
69238131209•Amneal Pharmaceuticals NY LLC
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
67877046405•Ascend Laboratories, LLC
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
65862076090•Aurobindo Pharma Limited
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
31722061290•Camber Pharmaceuticals Inc.
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
62135044590•Chartwell RX LLC
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
72205001390•Novadoz Pharmaceuticals LLC
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
13668036005•Torrent Pharmaceuticals Limited
$0.0509
Save 1%
PREGABALIN 75 MG CAPSULE
Generic
62332012190•Alembic Pharmaceuticals Inc.
$0.0509
Save 1%

Related Drugs

Same classification

No related drugs found.

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy